Trump administration recommends pregnant women limit Tylenol, contradicting medical guidance

The Trump administration said on Monday that the use of Tilanol during pregnancy may be linked to an increased risk of autism and that pregnant women should reduce their use, which contradicts medical evidence.

At a White House press conference, President Donald Trump, surrounded by senior public health officials in the country, said that the Food and Drug Administration (FDA) will start notifying doctors immediately that “he strongly recommends that women be united from using Tilanol during pregnancy unless this is medically necessary.”

“They strongly recommend that they limit women from using Tilanol during pregnancy unless it is medically necessary,” Trump said. “This, for example, in cases of very high fever.”

Studies on this question have not shown a direct cause and influence. Some studies indicate a possible connection, but the main medical groups evaluated the evidence and continues to recommend asymaminophen as the safest pain reliever during pregnancy.

Trump and health officials said that the Food and Drug Administration (FDA) will update the brand of Asyaminophen, known as Tilanol, to “reflect the potential benefits in reducing some symptoms of autism.”

But Trump went further, as I address pregnant women directly during the press conference, saying: “Do not take Taylinol. There is no negative side. Do not take it.”

“You will be uncomfortable,” he added. “It will not be easy, perhaps. But don’t take it if you are pregnant. Don’t take Tilanol, and do not give him to the child after the child’s birth.”

At some point, Trump admitted that his statements were less dependent on scientific evidence and more on his private life experiences and “sound sense”.

“You know, I just make these phrases from me,” he said. “I do not make them from these doctors, because when they speak, as you know, different results, different studies, I talk about a lot of common sense. They also have it. They have a lot, a lot.

The reaction of major medical groups was strongly, expressing concern that pregnant women frustrated the use of acetaminophen even if they could benefit.

In a statement, Dr. Stephen Flechman, President of the American College of Obstetricians and Gynecologists (ACOG), said that the medical group recommends that it is the safest pain reliever during pregnancy.

“The suggestions that the use of acetaminophen in pregnancy causes autism not only about doctors, but also not responsible when considering the harmful and confusing message they send to pregnant patients, including those who may need to rely on this useful medicine during pregnancy.”

“Today’s announcement from HHS is not supported by a full set of scientific evidence and seriously simplifying the many and complex causes of neurological challenges in children. It is extremely disturbing that our federal health agencies are ready to issue an advertisement that affects the health and welfare of millions of people without supporting reliable data.”

On Monday evening, the Food and Drug Administration (FDA) issued its note to doctors about a possible link between acetaminophen during pregnancy and autism, which was measured more than the president’s assurances.

The note included a language that there was no evidence that Tilanol caused autism, and the connection is a continuous field of scientific debate.

“To be clear, while a association was described between acetaminophen and autism in many studies, no causal relationship has been created and there are violating studies in scientific literature,” I read the note. “The association is a continuous field of scientific discussion, and doctors must be aware of this issue in making clinical decisions.”

In a statement issued by Kenfo, Tilanol maker, on Sunday, the company said it believes that research shows that acetaminophen does not cause autism.

The statement said: “We do not face any suggestion otherwise, and we are very interested in the health risks that these expectations offer,” the statement said. “Acetaminophen is the safest option for the most secure pain for pregnant women as needed throughout their pregnancy. Without it, women face dangerous options: they suffer through cases such as fever that is likely to be harmful to both the mother and child or use more serious alternatives.”

Studies have been mixed on whether acetaminophen is linked to an increased risk of hyperactivity disorder, lack of attention or autism, but no published study found that the use of acetaminophen in pregnancy causes autism. There are also multiple studies that show that there is no connection between vaccines and autism.

and April 2024 StudyFunded by the National Health Institutes (NIH) published in Jama, I found that the use of acetaminophen during pregnancy was not linked to an increase in the risk of autism, hyperactivity disorder, attention lack or mental disability in children.

During the press conference, Federal officials were martyred August 2025 Palm Analysis Among the researchers in Mount Sinai, Harvard Chan College of Heath, the College of Public Health at the University of California, Los Angeles, may increase the risk of developing neurological disorders, including autism and ADHD, in children.

However, the authors of the informed analysis said that their work is not proven that Tilanol, who was taken during pregnancy causes autism, and did not recommend stopping pregnant patients using Tilanol.

“[A]Acetaminophen is acetaminophen is the only approved acetaminophen in order to reduce pain and fever during pregnancy, and it is an important tool for pregnant patients and their doctors, “co -author Dr. Andrea Bacarelli, Dean of the College and Professor of Environmental Health at Harvard Chan School for Public Health, ABC News said in a statement.

Kennedy and others were determined to find what was behind what he indicated in the name of “autism”.

The April report from the Disease Control Center found that about 31 years old was diagnosed with autism spectrum disorder (ASD) in 2022. For comparison, one out of 36 was diagnosed with ASD in 2020, according to the report.

This is also a rise of 150 children who were diagnosed with autism in 2000, and the data of the Center for Disease Control.

Medical experts told ABC News that they believed this increase due to better awareness, better access to examination and services, and expanding ASD definition.

Hellen Tweet Flosburg, director of the Excellence Center in Autism Research at Boston University and a member of the ECG alliance, told ABC News that researchers are studying many reasons for autism for decades and that the best work combines genetic, medical and environmental data.

She warned that revealing the results without ways or review of the peers risks anxiety from the public and undermining the efforts of the continuous research of the National Institutes of Health.

She said: “None of the golden standard parameters include announcing the results of a study in a press conference, nothing that includes conducting this study without revealing methods or research questions, but instead turning it into a big surprise.”

The administration also announced on Monday that it started a approval process for a real estate called Leucovorin, despite the limited evidence of benefit.

Leucovorin, which is usually used as part of cancer care, has shown an early promise in a handful of small studies that it may help the symptoms of some children with autism.

Usually, more strength studies will be needed to obtain new approval for food and drugs management. Doctors say that there can be some promise to this medicine, but be careful that more research is needed to understand how much this medicine helps – or even – this medicine.

In the press statement, GSK, the maker of the drug, did not mention the name, but he said he started an operation to expand approval.

During the press conference on Monday, the Minister of Health and Humanitarian Services Robert F. proposed. Kennedy Junior also said that the childhood vaccine schedule can contribute to autism, which contradicts years of research that has not found any link between the two.